Quinazolone RVX-208 effect on liver carcinoma cell line - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS5340

Quinazolone RVX-208 effect on liver carcinoma cell line

Analysis of HepG2 liver carcinoma cells treated with the quinazolone RVX-208 or the triazolothienodiazepine JQ1, a BET bromodomain (BD) inhibitor. BET protein dysfunction is linked to cancer. Results provide insight into the difference in affinity of RVX-208 for the 1st and 2nd BDs in BET proteins.

Organism:: Homo sapiens

Type:: Expression profiling by array, transformed count, 3 agent sets

Platform:: GPL6244
Series:: GSE51143
8 Samples

Download data: CEL

DataSet

Accession:: GDS5340

ID:: 5340

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Full text in PMC
PMC links
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Related DataSets for GEO Profiles (Select 122569993) (1)
GEO DataSets
Quinazolone RVX-208 effect on liver carcinoma cell line
Quinazolone RVX-208 effect on liver carcinoma cell line
Accession: GDS5340

GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets